RMD

ResMed
D

RMD

Arincen97/100B
235.255
USD
-4.06
(-1.69%)
Market Closed
Last updated: · Delayed 15 min
Fair value294.55Plus-20%185Price 235.26478
Q2 FY2027 · Earnings report
EPS estimate 3.03Revenue estimate 1.46B
OverviewFinancialsForecastEarningsDividendsCompany

ResMed net income 1993–2027

ResMed earned 418.41M USD in Q1 FY2027, the three months to 30 September 2026, up 20.0% on the same quarter a year before. ResMed's net income over the last twelve months was 1.59B USD, up 10.8% on the twelve months before. In fiscal year 2026 it earned 1.52B USD, up 8.8% on the year before.

Last updated 6 Nov 2026 · Next report 28 Jan 2027

Net income

Net income · +15.8% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20261.59B+10.80%27.79%5.73B
FY202630 Jun 20261.52B+8.75%26.94%5.65B
FY202530 Jun 20251.40B+37.20%27.22%5.15B
FY202430 Jun 20241.02B+13.75%21.79%4.69B
FY202330 Jun 2023897.56M+15.15%21.25%4.22B
FY202230 Jun 2022779.44M+64.26%21.78%3.58B
FY202130 Jun 2021474.51M-23.67%14.84%3.20B
FY202030 Jun 2020621.67M+53.65%21.02%2.96B
FY201930 Jun 2019404.59M+28.20%15.52%2.61B
FY201830 Jun 2018315.59M-7.80%13.49%2.34B
FY201730 Jun 2017342.28M-2.87%16.56%2.07B
FY201630 Jun 2016352.41M-0.14%19.17%1.84B
FY201530 Jun 2015352.89M+2.20%21.02%1.68B
FY201430 Jun 2014345.27M+12.42%22.20%1.55B
FY201330 Jun 2013307.13M+20.52%20.28%1.51B
FY201230 Jun 2012254.85M+12.28%18.62%1.37B
FY201130 Jun 2011226.99M+19.41%18.26%1.24B
FY201030 Jun 2010190.09M+29.80%17.40%1.09B
FY200930 Jun 2009146.45M+32.77%15.91%920.74M
FY200830 Jun 2008110.30M+66.36%13.20%835.40M
FY200730 Jun 200766.30M-24.84%9.26%716.33M
FY200630 Jun 200688.21M+36.16%14.53%607.00M
FY200530 Jun 200564.79M+13.09%15.23%425.51M
FY200430 Jun 200457.28M+25.27%16.88%339.34M
FY200330 Jun 200345.73M+21.92%16.72%273.57M
FY200230 Jun 200237.51M+222.49%18.38%204.08M
FY200130 Jun 200111.63M-47.67%7.50%155.16M
FY200030 Jun 200022.23M+38.05%19.22%115.62M
FY199930 Jun 199916.10M+51.89%18.17%88.60M
FY199830 Jun 199810.60M+41.33%15.94%66.50M
FY199730 Jun 19977.50M+66.67%15.24%49.20M
FY199630 Jun 19964.50M+60.71%13.01%34.60M
FY199530 Jun 19952.80M+133.33%11.91%23.50M
FY199430 Jun 19941.20M+50.00%8.63%13.90M
FY199330 Jun 1993800.00K—10.39%7.70M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about ResMed's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.